戻る
Scinai Immunotherapeutics Ltd (SCNI)価格
SCNI 株価推移チャート
SCNI 収入
Scinai Immunotherapeutics Ltd
$0.86
-4.86%
$-0.04
終値： Jan 16, 16:00:00 GMT-5
$0.87
0.57%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.9092
始値
$0.954
当日レンジ
$0.865 - $0.963
52週レンジ
$0.613 - $6.18
取引高
11.3K
平均取引高
52.4K
1株当たり利益(TTM)
0.00
配当利回り
--
時価総額
$2.7M
SCNIとは何ですか？
Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.